David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$397M |
| 2 |
YHOO
Yahoo Inc
YHOO
|
+$342M |
| 3 |
Bank of America
BAC
|
+$322M |
| 4 |
Citigroup
C
|
+$260M |
| 5 |
Booking.com
BKNG
|
+$219M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$637M |
| 2 |
BRCM
BROADCOM CORP CL-A
BRCM
|
+$397M |
| 3 |
Gilead Sciences
GILD
|
+$358M |
| 4 |
Phillips 66
PSX
|
+$330M |
| 5 |
Apple
AAPL
|
+$320M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.78% |
| 2 | Technology | 11.11% |
| 3 | Financials | 10% |
| 4 | Consumer Discretionary | 8.83% |
| 5 | Communication Services | 8.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1776
Larimar Therapeutics
LRMR
$433M
| $2.24M | ﹤0.01% |
+27,956
| New | +$2.21M |
|
1777
PUT
Southwest Airlines
LUV
$19.9B
| $2.24M | ﹤0.01% |
50,000
-100,100
| -67% | -$4.07M |
|
1778
Stepan Co
SCL
$1.42B
| $2.24M | ﹤0.01% |
40,522
+3,187
| +9% | +$153K |
|
1779
Icon
ICLR
$13B
| $2.24M | ﹤0.01% |
29,818
-14,478
| -33% | -$1.01M |
|
1780
LivePerson
LPSN
$33.4M
| $2.24M | ﹤0.01% |
25,489
-1,526
| -6% | -$126K |
|
1781
POSCO
PKX
$17.7B
| $2.24M | ﹤0.01% |
47,262
+12,356
| +35% | +$489K |
|
|
WLL
1782
CALL
DELISTED
Whiting Petroleum Corporation
WLL
| $2.23M | ﹤0.01% |
933
-58
| -6% | -$114K |
|
1783
LXP Industrial Trust
LXP
$3.6B
| $2.23M | ﹤0.01% |
51,837
+7,027
| +16% | +$270K |
|
1784
CALL
United Therapeutics
UTHR
$22.2B
| $2.23M | ﹤0.01% |
20,000
| – | – |
|
1785
CALL
Charter Communications
CHTR
$18.4B
| $2.23M | ﹤0.01% |
11,000
| – | – |
|
|
CHSP
1786
DELISTED
Chesapeake Lodging Trust
CHSP
| $2.22M | ﹤0.01% |
83,981
+33,085
| +65% | +$834K |
|
|
NORD
1787
DELISTED
Nord Anglia Education, Inc.
NORD
| $2.22M | ﹤0.01% |
106,191
-70,542
| -40% | -$1.29M |
|
|
CMA
1788
PUT
DELISTED
Comerica
CMA
| $2.21M | ﹤0.01% |
+58,300
| New | +$2.1M |
|
1789
PUT
BioMarin Pharmaceuticals
BMRN
$12.7B
| $2.2M | ﹤0.01% |
26,700
-39,500
| -60% | -$3.21M |
|
|
MNK
1790
CALL
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $2.2M | ﹤0.01% |
35,900
-20,000
| -36% | -$1.28M |
|
1791
PUT
O-I Glass
OI
$1.14B
| $2.19M | ﹤0.01% |
+137,500
| New | +$1.97M |
|
1792
Shinhan Financial Group
SHG
$36.4B
| $2.19M | ﹤0.01% |
+62,221
| New | +$2.03M |
|
1793
Steven Madden
SHOO
$3.3B
| $2.19M | ﹤0.01% |
88,736
+63,744
| +255% | +$1.42M |
|
|
MNR
1794
DELISTED
Monmouth Real Estate Investment Corp
MNR
| $2.19M | ﹤0.01% |
183,994
+81,099
| +79% | +$874K |
|
1795
TTEC Holdings
TTEC
$67.5M
| $2.18M | ﹤0.01% |
78,652
+9,936
| +14% | +$266K |
|
1796
American Public Education
APEI
$842M
| $2.18M | ﹤0.01% |
+105,772
| New | +$1.86M |
|
1797
Sonoco
SON
$5.69B
| $2.18M | ﹤0.01% |
44,885
-19,109
| -30% | -$813K |
|
|
FDML
1798
DELISTED
Federal-Mogul Holdings Corporation
FDML
| $2.18M | ﹤0.01% |
220,271
+189,220
| +609% | +$1.18M |
|
1799
National CineMedia
NCMI
$248M
| $2.17M | ﹤0.01% |
14,266
+358
| +3% | +$53.6K |
|
|
ANK
1800
DELISTED
ATLANTIC TELE-NETWORK,INC
ANK
| $2.16M | ﹤0.01% |
28,524
+14,821
| +108% | +$1.12M |
|
Similar funds
David Shaw's Q1 2016 Portfolio in Review
As of Q1 2016, David Shaw held 4,137 positions worth $55.7B, down 17% from $67.2B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.
David Shaw withdrew a net $9.72B in Q1 2016, closing 773 positions and reducing 1,495 holdings. Its most notable exit was PRECISION CASTPARTS CORP, an estimated $637M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 13% a quarter earlier, followed by Technology and Financials.
Against the trend, David Shaw opened a new position in EQT Corp worth $47.6M.
- David Shaw's largest Q1 2016 buy was EQT Corp: 1,300,361 shares worth $47.6M.
- David Shaw added most to Allergan plc in Q1 2016, an estimated $397M increase.
- David Shaw's biggest Q1 2016 reduction was Gilead Sciences, cutting an estimated $358M.
- David Shaw fully exited PRECISION CASTPARTS CORP in Q1 2016, selling an estimated $637M.
- David Shaw's ten largest holdings make up 9.5% of its $55.7B portfolio in Q1 2016.
- David Shaw opened 382 new positions and closed 773 in Q1 2016.
- David Shaw's portfolio value fell 17% quarter-over-quarter to $55.7B.
Based on D.E. Shaw & Co's 13F filing for Q1 2016, filed 16 May 2016.